US Appeals Court Upholds Ban on Amgen’s (JOBS) Anemia Drug

Bookmark and Share

Reuters -- A federal court let stand a ban on the U.S. sale of Roche Holding AG's Mircera, a rival to Amgen's blockbuster anemia drugs.
MORE ON THIS TOPIC